Cem Gabay

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Cem Gabay, Paul Emery, Ronald van Vollenhoven et al. · The Lancet · 2013 · 673 citations

Life Sciences, Immunology, Pharmacotherapy +13

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

Daniëlle M. Gerlag, Karim Raza, Lisa G. M. van Baarsen et al. · Annals of the Rheumatic Diseases · 2012 · 470 citations · Full text

Life Sciences, Immunology, Autoimmunity +15

Prevotella copri in individuals at risk for rheumatoid arthritis

D. Alpizar-Rodriguez, Till Robin Lesker, Achim Gronow et al. · Annals of the Rheumatic Diseases · 2019 · 432 citations · Full text

Life Sciences, Immunology, Microbiology +17

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Josef S Smolen, R. B. M. Landewé, F. C. Breedveld et al. · Annals of the Rheumatic Diseases · 2010 · 410 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome

Eric S. Weiss, Charlotte Girard, Dirk Holzinger et al. · Blood · 2018 · 395 citations · Full text

Life Sciences, Immunology, Pathology +12